Efficacy and Safety of the Triple Therapy Containing Ilaprazole, Levofloxacin, and Amoxicillin as First-Line Treatment in <i>Helicobacter pylori</i> Infections

<table class="table-group" id="tab5"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left"></td><td class="align_center"><i>n</i> (%)</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">All</td><td class="align_center">8 (10%)</td></tr><tr><td class="align_left">Nausea/vomiting</td><td class="align_center">3</td></tr><tr><td class="align_left">Dizziness</td><td class="align_center">2</td></tr><tr><td class="align_left">Abdominal pain</td><td class="align_center">1</td></tr><tr><td class="align_left">Diarrhea</td><td class="align_center">1</td></tr><tr><td class="align_left">Headache</td><td class="align_center">1</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Gastroenterology Research and Practice

tab5

Table 5

Table 5: Efficacy and Safety of the Triple Therapy Containing Ilaprazole, Levofloxacin, and Amoxicillin as First-Line Treatment in <i>Helicobacter pylori</i> Infections 

Table 5 | Efficacy and Safety of the Triple Therapy Containing Ilaprazole, Levofloxacin, and Amoxicillin as First-Line Treatment in Helicobacter pylori Infections 